Quinn Opportunity Partners LLC Sells 65,000 Shares of Kenvue Inc. (NYSE:KVUE)

Quinn Opportunity Partners LLC lowered its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 76.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,000 shares of the company's stock after selling 65,000 shares during the period. Quinn Opportunity Partners LLC's holdings in Kenvue were worth $427,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Zuckerman Investment Group LLC increased its holdings in shares of Kenvue by 18.7% in the 4th quarter. Zuckerman Investment Group LLC now owns 1,122,061 shares of the company's stock worth $23,821,000 after buying an additional 176,632 shares during the last quarter. Treasurer of the State of North Carolina increased its stake in Kenvue by 3.3% in the fourth quarter. Treasurer of the State of North Carolina now owns 864,896 shares of the company's stock valued at $18,466,000 after acquiring an additional 27,950 shares during the last quarter. Neuberger Berman Group LLC lifted its stake in Kenvue by 0.4% during the fourth quarter. Neuberger Berman Group LLC now owns 265,473 shares of the company's stock worth $5,668,000 after purchasing an additional 1,165 shares during the last quarter. Colonial Trust Advisors boosted its holdings in shares of Kenvue by 1.6% in the 4th quarter. Colonial Trust Advisors now owns 156,634 shares of the company's stock worth $3,344,000 after purchasing an additional 2,510 shares in the last quarter. Finally, Scotia Capital Inc. increased its position in shares of Kenvue by 3.2% during the 4th quarter. Scotia Capital Inc. now owns 202,825 shares of the company's stock valued at $4,331,000 after purchasing an additional 6,252 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

KVUE has been the topic of a number of analyst reports. Redburn Atlantic started coverage on Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target on the stock. UBS Group lowered their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Barclays cut their price target on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Monday. Canaccord Genuity Group upped their price objective on shares of Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research note on Wednesday, March 5th. Finally, Evercore ISI started coverage on Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Kenvue has a consensus rating of "Hold" and a consensus price target of $24.42.

Kenvue Stock Up 1.1 %

NYSE KVUE traded up $0.25 during trading hours on Tuesday, reaching $22.96. 22,262,776 shares of the company's stock traded hands, compared to its average volume of 16,951,647. The firm has a market cap of $43.87 billion, a PE ratio of 43.31, a PEG ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The firm has a 50-day simple moving average of $22.69 and a 200 day simple moving average of $22.40.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.57%. The ex-dividend date was Wednesday, February 12th. Kenvue's payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.